Similarly a ligand for a different co-stimulatory receptor CD40 was linked to a bispecific FAP antibody to ensure activation of CD40 was only induced around FAP-expressing cells in an experimental model of murine head and neck cancer that synergised with radiotherapy causing tumour regression and long term survival (94) (Figure 2C). The gene discussed is FAP; the disease is neoplasm.